Hinge Health, Inc. (HNGE) Stock Analysis
Healthcare · Health Information Services
Sell if holding. Analyst target reached at $67.23 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Health Care Service Corporation (17.5%).
Hinge Health is a digital musculoskeletal (MSK) care platform serving self-insured employers and health plans, using AI-powered motion tracking and licensed physical therapists to treat joint and muscle conditions remotely. Revenue is generated on a per-member engagement basis,... Read more
Sell if holding. Analyst target reached at $67.23 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Health Care Service Corporation (17.5%). Chart setup: No clear chart pattern; technical signals are mixed. Score 6.3/10, moderate confidence.
Passes 6/8 gates (positive momentum, clean insider activity, news boost analyst 0.70, earnings proximity 50d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.
Recent developments
updated 2026-06-15Recent Developments — Hinge Health, Inc.
Latest news
- NEWS HNGE Stock Up on Q1 Earnings & Revenue Beat, 2026 Outlook Improved - Zacks Investment Research — Zacks Investment Research positive
- NEWS Hinge Health (NYSE:HNGE) Given New $63.00 Price Target at Needham & Company LLC - MarketBeat — MarketBeat positive
- NEWS Citizens raises Hinge Health stock price target on strong Q1 results - Investing.com Canada — Investing.com Canada positive
- NEWS Hinge Health (NYSE:HNGE) Sees Large Volume Increase - Here's What Happened - MarketBeat — MarketBeat neutral
- NEWS Earnings Preview: Hinge Health to Report Financial Results Post-market on May 05 - Moomoo — Moomoo neutral
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerHealth Care Service Corporation18%10-K Item 1A: 'client contracts through (i) Health Care Service Corporation ("HCSC") accounted for 17.5% and 17.1% of our revenue, respectively'
- MEDIUMCustomerElevance Health, Inc.14%10-K Item 1A: '(ii) Elevance Health, Inc., formerly known as Anthem, Inc. ("Elevance"), accounted for 13.7% and 14.0% of our revenue, respectively'
- MEDIUMCustomerAetna Life Insurance Company11%10-K Item 1A: '(iii) Aetna Life Insurance Company ("Aetna") accounted for 10.5% and 11.6% of our revenue, respectively'
Material Events(8-K, last 90d)
- 2026-03-17Item 5.02LOWTyler Sloat appointed as Class I director effective March 16, 2026, serving as Chair of Compensation Committee and member of Audit Committee. Mr. Sloat is COO of Freshworks Inc. No officer departure involved.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $67.23 — A.R:R 0.2:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Health Care Service Corporation (17.5%). Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $62.52. Score 6.3/10, moderate confidence.
Take-profit target: $69.12 (+2.8% upside). Prior stop was $62.52. Stop-loss: $62.52.
Concentration risk — Customer: Health Care Service Corporation (17.5%); Analyst target reached - limited upside remaining; Near 52-week high (-0.5% away).
Hinge Health, Inc. trades at a P/E of N/A (forward 20.0). TrendMatrix value score: 6.2/10. Verdict: Sell.
22 analysts cover HNGE with a consensus score of 4.1/5. Average price target: $77.
What does Hinge Health, Inc. do?Hinge Health is a digital musculoskeletal (MSK) care platform serving self-insured employers and health plans, using...
Hinge Health is a digital musculoskeletal (MSK) care platform serving self-insured employers and health plans, using AI-powered motion tracking and licensed physical therapists to treat joint and muscle conditions remotely. Revenue is generated on a per-member engagement basis, primarily through contracts with large national health plans acting as channel partners. Client contracts through partners accounted for 82% of revenue in 2025, with HCSC at 17.5%, Elevance at 13.7%, and Aetna at 10.5%.